Efficacy of three consecutive therapeutic plasma exchanges in major ABO‐incompatible hematopoietic stem cell transplantation

摘要

Abstract Introduction We retrospectively analyzed data of recipients who underwent three consecutive therapeutic plasma exchanges (TPEs) before major ABO‐incompatible (ABOi) hematopoietic stem cell transplantation (HSCT) in our hospital from 2012 to 2017 and evaluated the efficacy of TPE for successful ABOi HSCT. Materials and methods We investigated the efficacy of TPE in 29 recipients with major ABOi HSCT based on the following: (1) requirement of red blood cell (RBC) transfusion during 100?days, (2) erythrocyte engraftment by reticulocyte count at 3 months, and (3) erythropoiesis recovery by bone marrow examination at 1 month and 3 months after ABOi HSCT. Results IgM and IgG donor‐specific isoagglutinins (DSIs) of 31 cases of TPE were significantly decreased after three consecutive TPEs (IgM median, 1:32 to 1:2, P ??.0001; IgG median, 1:256 to 1:8, P ??.0001). We divided a total of 31 TPEs into two groups depending on their final DSI titers after TPE (group F, DSI??1:16; group S, DSI?≤?1:16). RBC transfusions were required more by group F (median, 12?units) than those by group S (median, 2 units, P ?=?.001). Relative frequencies of erythrocyte engraftment and normal erythropoiesis after ABOi HSCT showed higher tendencies in group S than those in group F. Discussion Our study demonstrated that three consecutive TPEs were effective in reducing DSI titer in major ABOi HSCT. Reduction of pretransplant DSI in recipients could decrease requirement for RBC transfusion. Three consecutive TPEs are necessary for successful erythrocyte engraftment and normal erythropoiesis in this setting.